0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-26K13655
Home | Market Reports | Health| Medical Devices & Equipment
Global Nuclear Radiopharmaceutical Market Research Report 2023
BUY CHAPTERS

Global Nuclear Radiopharmaceutical Market Insights, Forecast to 2030

Code: QYRE-Auto-26K13655
Report
December 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Radiopharmaceutical Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nuclear Radiopharmaceutical Market

Nuclear Radiopharmaceutical Market

Nuclear Radiopharmaceuticals consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
The global Nuclear Radiopharmaceutical market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Nuclear Radiopharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Nuclear Radiopharmaceutical, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nuclear Radiopharmaceutical, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nuclear Radiopharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Nuclear Radiopharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Nuclear Radiopharmaceutical sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Nuclear Radiopharmaceutical Market Report

Report Metric Details
Report Name Nuclear Radiopharmaceutical Market
CAGR 5%
Segment by Type
  • Diagnostic
  • Therapeutic
Segment by Application
  • Oncology
  • Thyroid
  • Cardiology
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, China Isotope & Radiation, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Nuclear Radiopharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Nuclear Radiopharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nuclear Radiopharmaceutical sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nuclear Radiopharmaceutical Market report?

Ans: The main players in the Nuclear Radiopharmaceutical Market are Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution, China Isotope & Radiation, Ciaeriar, Shanghai Atom Kexing Pharmaceutical Co.,Ltd.

What are the Application segmentation covered in the Nuclear Radiopharmaceutical Market report?

Ans: The Applications covered in the Nuclear Radiopharmaceutical Market report are Oncology, Thyroid, Cardiology, Others

What are the Type segmentation covered in the Nuclear Radiopharmaceutical Market report?

Ans: The Types covered in the Nuclear Radiopharmaceutical Market report are Diagnostic, Therapeutic

1 Study Coverage
1.1 Nuclear Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Radiopharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Market by Application
1.3.1 Global Nuclear Radiopharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nuclear Radiopharmaceutical Sales Estimates and Forecasts 2019-2030
2.2 Global Nuclear Radiopharmaceutical Revenue by Region
2.2.1 Global Nuclear Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Nuclear Radiopharmaceutical Revenue by Region (2019-2024)
2.2.3 Global Nuclear Radiopharmaceutical Revenue by Region (2025-2030)
2.2.4 Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2030)
2.3 Global Nuclear Radiopharmaceutical Sales Estimates and Forecasts 2019-2030
2.4 Global Nuclear Radiopharmaceutical Sales by Region
2.4.1 Global Nuclear Radiopharmaceutical Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Nuclear Radiopharmaceutical Sales by Region (2019-2024)
2.4.3 Global Nuclear Radiopharmaceutical Sales by Region (2025-2030)
2.4.4 Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Nuclear Radiopharmaceutical Sales by Manufacturers
3.1.1 Global Nuclear Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.1.2 Global Nuclear Radiopharmaceutical Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Radiopharmaceutical in 2023
3.2 Global Nuclear Radiopharmaceutical Revenue by Manufacturers
3.2.1 Global Nuclear Radiopharmaceutical Revenue by Manufacturers (2019-2024)
3.2.2 Global Nuclear Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Nuclear Radiopharmaceutical Revenue in 2023
3.3 Global Key Players of Nuclear Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Nuclear Radiopharmaceutical Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Offered and Application
3.8 Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nuclear Radiopharmaceutical Sales by Type
4.1.1 Global Nuclear Radiopharmaceutical Historical Sales by Type (2019-2024)
4.1.2 Global Nuclear Radiopharmaceutical Forecasted Sales by Type (2025-2030)
4.1.3 Global Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
4.2 Global Nuclear Radiopharmaceutical Revenue by Type
4.2.1 Global Nuclear Radiopharmaceutical Historical Revenue by Type (2019-2024)
4.2.2 Global Nuclear Radiopharmaceutical Forecasted Revenue by Type (2025-2030)
4.2.3 Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
4.3 Global Nuclear Radiopharmaceutical Price by Type
4.3.1 Global Nuclear Radiopharmaceutical Price by Type (2019-2024)
4.3.2 Global Nuclear Radiopharmaceutical Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Nuclear Radiopharmaceutical Sales by Application
5.1.1 Global Nuclear Radiopharmaceutical Historical Sales by Application (2019-2024)
5.1.2 Global Nuclear Radiopharmaceutical Forecasted Sales by Application (2025-2030)
5.1.3 Global Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
5.2 Global Nuclear Radiopharmaceutical Revenue by Application
5.2.1 Global Nuclear Radiopharmaceutical Historical Revenue by Application (2019-2024)
5.2.2 Global Nuclear Radiopharmaceutical Forecasted Revenue by Application (2025-2030)
5.2.3 Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
5.3 Global Nuclear Radiopharmaceutical Price by Application
5.3.1 Global Nuclear Radiopharmaceutical Price by Application (2019-2024)
5.3.2 Global Nuclear Radiopharmaceutical Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Nuclear Radiopharmaceutical Market Size by Type
6.1.1 US & Canada Nuclear Radiopharmaceutical Sales by Type (2019-2030)
6.1.2 US & Canada Nuclear Radiopharmaceutical Revenue by Type (2019-2030)
6.2 US & Canada Nuclear Radiopharmaceutical Market Size by Application
6.2.1 US & Canada Nuclear Radiopharmaceutical Sales by Application (2019-2030)
6.2.2 US & Canada Nuclear Radiopharmaceutical Revenue by Application (2019-2030)
6.3 US & Canada Nuclear Radiopharmaceutical Market Size by Country
6.3.1 US & Canada Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Nuclear Radiopharmaceutical Sales by Country (2019-2030)
6.3.3 US & Canada Nuclear Radiopharmaceutical Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Nuclear Radiopharmaceutical Market Size by Type
7.1.1 Europe Nuclear Radiopharmaceutical Sales by Type (2019-2030)
7.1.2 Europe Nuclear Radiopharmaceutical Revenue by Type (2019-2030)
7.2 Europe Nuclear Radiopharmaceutical Market Size by Application
7.2.1 Europe Nuclear Radiopharmaceutical Sales by Application (2019-2030)
7.2.2 Europe Nuclear Radiopharmaceutical Revenue by Application (2019-2030)
7.3 Europe Nuclear Radiopharmaceutical Market Size by Country
7.3.1 Europe Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Nuclear Radiopharmaceutical Sales by Country (2019-2030)
7.3.3 Europe Nuclear Radiopharmaceutical Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Nuclear Radiopharmaceutical Market Size
8.1.1 China Nuclear Radiopharmaceutical Sales (2019-2030)
8.1.2 China Nuclear Radiopharmaceutical Revenue (2019-2030)
8.2 China Nuclear Radiopharmaceutical Market Size by Application
8.2.1 China Nuclear Radiopharmaceutical Sales by Application (2019-2030)
8.2.2 China Nuclear Radiopharmaceutical Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Nuclear Radiopharmaceutical Market Size by Type
9.1.1 Asia Nuclear Radiopharmaceutical Sales by Type (2019-2030)
9.1.2 Asia Nuclear Radiopharmaceutical Revenue by Type (2019-2030)
9.2 Asia Nuclear Radiopharmaceutical Market Size by Application
9.2.1 Asia Nuclear Radiopharmaceutical Sales by Application (2019-2030)
9.2.2 Asia Nuclear Radiopharmaceutical Revenue by Application (2019-2030)
9.3 Asia Nuclear Radiopharmaceutical Sales by Region
9.3.1 Asia Nuclear Radiopharmaceutical Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Nuclear Radiopharmaceutical Revenue by Region (2019-2030)
9.3.3 Asia Nuclear Radiopharmaceutical Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Market Size by Type
10.1.1 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Market Size by Application
10.2.1 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country
10.3.1 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Nihon Medi-Physics Co.,Ltd.
11.1.1 Nihon Medi-Physics Co.,Ltd. Company Information
11.1.2 Nihon Medi-Physics Co.,Ltd. Overview
11.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Nihon Medi-Physics Co.,Ltd. Recent Developments
11.2 Curium Pharma
11.2.1 Curium Pharma Company Information
11.2.2 Curium Pharma Overview
11.2.3 Curium Pharma Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Curium Pharma Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Curium Pharma Recent Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Company Information
11.3.2 Cardinal Health Overview
11.3.3 Cardinal Health Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Cardinal Health Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cardinal Health Recent Developments
11.4 Bayer Global
11.4.1 Bayer Global Company Information
11.4.2 Bayer Global Overview
11.4.3 Bayer Global Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bayer Global Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Global Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Information
11.5.2 GE Healthcare Overview
11.5.3 GE Healthcare Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GE Healthcare Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GE Healthcare Recent Developments
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Information
11.6.2 Mallinckrodt Pharmaceuticals Overview
11.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mallinckrodt Pharmaceuticals Recent Developments
11.7 Bracco Group
11.7.1 Bracco Group Company Information
11.7.2 Bracco Group Overview
11.7.3 Bracco Group Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Bracco Group Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bracco Group Recent Developments
11.8 Advanced Molecular-imaging Solution
11.8.1 Advanced Molecular-imaging Solution Company Information
11.8.2 Advanced Molecular-imaging Solution Overview
11.8.3 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Advanced Molecular-imaging Solution Recent Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Information
11.9.2 China Isotope & Radiation Overview
11.9.3 China Isotope & Radiation Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 China Isotope & Radiation Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China Isotope & Radiation Recent Developments
11.10 Ciaeriar
11.10.1 Ciaeriar Company Information
11.10.2 Ciaeriar Overview
11.10.3 Ciaeriar Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Ciaeriar Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ciaeriar Recent Developments
11.11 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
11.11.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
11.11.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Overview
11.11.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nuclear Radiopharmaceutical Industry Chain Analysis
12.2 Nuclear Radiopharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nuclear Radiopharmaceutical Production Mode & Process
12.4 Nuclear Radiopharmaceutical Sales and Marketing
12.4.1 Nuclear Radiopharmaceutical Sales Channels
12.4.2 Nuclear Radiopharmaceutical Distributors
12.5 Nuclear Radiopharmaceutical Customers
13 Market Dynamics
13.1 Nuclear Radiopharmaceutical Industry Trends
13.2 Nuclear Radiopharmaceutical Market Drivers
13.3 Nuclear Radiopharmaceutical Market Challenges
13.4 Nuclear Radiopharmaceutical Market Restraints
14 Key Findings in The Global Nuclear Radiopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Diagnostic
    Table 3. Major Manufacturers of Therapeutic
    Table 4. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2024)
    Table 9. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2025-2030)
    Table 10. Global Nuclear Radiopharmaceutical Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (Units)
    Table 12. Global Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (Units)
    Table 13. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2024)
    Table 14. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2025-2030)
    Table 15. Global Nuclear Radiopharmaceutical Sales by Manufacturers (2019-2024) & (Units)
    Table 16. Global Nuclear Radiopharmaceutical Sales Share by Manufacturers (2019-2024)
    Table 17. Global Nuclear Radiopharmaceutical Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Nuclear Radiopharmaceutical Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Nuclear Radiopharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Nuclear Radiopharmaceutical Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Nuclear Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Nuclear Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Radiopharmaceutical as of 2023)
    Table 23. Global Key Manufacturers of Nuclear Radiopharmaceutical, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Nuclear Radiopharmaceutical, Product Offered and Application
    Table 25. Global Key Manufacturers of Nuclear Radiopharmaceutical, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 28. Global Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 29. Global Nuclear Radiopharmaceutical Sales Share by Type (2019-2024)
    Table 30. Global Nuclear Radiopharmaceutical Sales Share by Type (2025-2030)
    Table 31. Global Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Nuclear Radiopharmaceutical Revenue Share by Type (2019-2024)
    Table 34. Global Nuclear Radiopharmaceutical Revenue Share by Type (2025-2030)
    Table 35. Nuclear Radiopharmaceutical Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Nuclear Radiopharmaceutical Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 38. Global Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 39. Global Nuclear Radiopharmaceutical Sales Share by Application (2019-2024)
    Table 40. Global Nuclear Radiopharmaceutical Sales Share by Application (2025-2030)
    Table 41. Global Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Nuclear Radiopharmaceutical Revenue Share by Application (2019-2024)
    Table 44. Global Nuclear Radiopharmaceutical Revenue Share by Application (2025-2030)
    Table 45. Nuclear Radiopharmaceutical Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Nuclear Radiopharmaceutical Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 48. US & Canada Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 49. US & Canada Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 52. US & Canada Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 53. US & Canada Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
    Table 59. US & Canada Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
    Table 60. Europe Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 61. Europe Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 62. Europe Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 65. Europe Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 66. Europe Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
    Table 72. Europe Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
    Table 73. China Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 74. China Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 75. China Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 78. China Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 79. China Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 82. Asia Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 83. Asia Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 86. Asia Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 87. Asia Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Nuclear Radiopharmaceutical Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Nuclear Radiopharmaceutical Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Nuclear Radiopharmaceutical Sales by Region (2019-2024) & (Units)
    Table 93. Asia Nuclear Radiopharmaceutical Sales by Region (2025-2030) & (Units)
    Table 94. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Type (2019-2024) & (Units)
    Table 95. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Type (2025-2030) & (Units)
    Table 96. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Application (2019-2024) & (Units)
    Table 99. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Application (2025-2030) & (Units)
    Table 100. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country (2019-2024) & (Units)
    Table 106. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales by Country (2025-2030) & (Units)
    Table 107. Nihon Medi-Physics Co.,Ltd. Company Information
    Table 108. Nihon Medi-Physics Co.,Ltd. Description and Major Businesses
    Table 109. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Nihon Medi-Physics Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Nihon Medi-Physics Co.,Ltd. Recent Developments
    Table 112. Curium Pharma Company Information
    Table 113. Curium Pharma Description and Major Businesses
    Table 114. Curium Pharma Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Curium Pharma Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Curium Pharma Recent Developments
    Table 117. Cardinal Health Company Information
    Table 118. Cardinal Health Description and Major Businesses
    Table 119. Cardinal Health Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Cardinal Health Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Cardinal Health Recent Developments
    Table 122. Bayer Global Company Information
    Table 123. Bayer Global Description and Major Businesses
    Table 124. Bayer Global Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Bayer Global Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Bayer Global Recent Developments
    Table 127. GE Healthcare Company Information
    Table 128. GE Healthcare Description and Major Businesses
    Table 129. GE Healthcare Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. GE Healthcare Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GE Healthcare Recent Developments
    Table 132. Mallinckrodt Pharmaceuticals Company Information
    Table 133. Mallinckrodt Pharmaceuticals Description and Major Businesses
    Table 134. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Mallinckrodt Pharmaceuticals Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Mallinckrodt Pharmaceuticals Recent Developments
    Table 137. Bracco Group Company Information
    Table 138. Bracco Group Description and Major Businesses
    Table 139. Bracco Group Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Bracco Group Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Bracco Group Recent Developments
    Table 142. Advanced Molecular-imaging Solution Company Information
    Table 143. Advanced Molecular-imaging Solution Description and Major Businesses
    Table 144. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Advanced Molecular-imaging Solution Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Advanced Molecular-imaging Solution Recent Developments
    Table 147. China Isotope & Radiation Company Information
    Table 148. China Isotope & Radiation Description and Major Businesses
    Table 149. China Isotope & Radiation Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. China Isotope & Radiation Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. China Isotope & Radiation Recent Developments
    Table 152. Ciaeriar Company Information
    Table 153. Ciaeriar Description and Major Businesses
    Table 154. Ciaeriar Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 155. Ciaeriar Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Ciaeriar Recent Developments
    Table 157. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
    Table 158. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Description and Major Businesses
    Table 159. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 160. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Nuclear Radiopharmaceutical Distributors List
    Table 165. Nuclear Radiopharmaceutical Customers List
    Table 166. Nuclear Radiopharmaceutical Market Trends
    Table 167. Nuclear Radiopharmaceutical Market Drivers
    Table 168. Nuclear Radiopharmaceutical Market Challenges
    Table 169. Nuclear Radiopharmaceutical Market Restraints
    Table 170. Research Programs/Design for This Report
    Table 171. Key Data Information from Secondary Sources
    Table 172. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nuclear Radiopharmaceutical Product Picture
    Figure 2. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Nuclear Radiopharmaceutical Market Share by Type in 2023 & 2030
    Figure 4. Diagnostic Product Picture
    Figure 5. Therapeutic Product Picture
    Figure 6. Global Nuclear Radiopharmaceutical Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Nuclear Radiopharmaceutical Market Share by Application in 2023 & 2030
    Figure 8. Oncology
    Figure 9. Thyroid
    Figure 10. Cardiology
    Figure 11. Others
    Figure 12. Nuclear Radiopharmaceutical Report Years Considered
    Figure 13. Global Nuclear Radiopharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Nuclear Radiopharmaceutical Revenue 2019-2030 (US$ Million)
    Figure 15. Global Nuclear Radiopharmaceutical Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Nuclear Radiopharmaceutical Revenue Market Share by Region (2019-2030)
    Figure 17. Global Nuclear Radiopharmaceutical Sales 2019-2030 ((Units)
    Figure 18. Global Nuclear Radiopharmaceutical Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
    Figure 20. US & Canada Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
    Figure 22. Europe Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
    Figure 24. China Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
    Figure 26. Asia (excluding China) Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales YoY (2019-2030) & (Units)
    Figure 28. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Nuclear Radiopharmaceutical Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Nuclear Radiopharmaceutical in the World: Market Share by Nuclear Radiopharmaceutical Revenue in 2023
    Figure 31. Global Nuclear Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 33. Global Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 34. Global Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 35. Global Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
    Figure 42. U.S. Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 45. Europe Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 47. Europe Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
    Figure 49. Europe Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
    Figure 50. Germany Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 51. France Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 55. China Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 56. China Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 57. China Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 58. China Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 60. Asia Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 62. Asia Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Nuclear Radiopharmaceutical Revenue Share by Region (2019-2030)
    Figure 64. Asia Nuclear Radiopharmaceutical Sales Share by Region (2019-2030)
    Figure 65. Japan Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 69. India Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Nuclear Radiopharmaceutical Sales Share by Country (2019-2030)
    Figure 76. Brazil Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Nuclear Radiopharmaceutical Revenue (2019-2030) & (US$ Million)
    Figure 81. Nuclear Radiopharmaceutical Value Chain
    Figure 82. Nuclear Radiopharmaceutical Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Fast Protein-free Blocking Buffer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18R18881
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Hard Oxygen Chamber Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35N18718
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Prefillable COP Polymer Syringes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2C19012
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Soft Oxygen Chamber Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38V18597
Fri Jan 31 00:00:00 UTC 2025

Add to Cart